Log in to save to my catalogue

Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines

Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1976411163

Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines

About this item

Full title

Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines

Publisher

United States: Public Library of Science

Journal title

PloS one, 2017-12, Vol.12 (12), p.e0188680

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Prognosis of childhood acute lymphoblastic leukemia (ALL) has been dramatically improved. However, prognosis of the cases refractory to primary therapy is still poor. Recent phase 2 study on the efficacy of combination chemotherapy with bortezomib (BTZ), a proteasome inhibitor, for refractory childhood ALL demonstrated favorable clinical outcomes....

Alternative Titles

Full title

Anti-leukemic activity of bortezomib and carfilzomib on B-cell precursor ALL cell lines

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1976411163

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1976411163

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0188680

How to access this item